Your browser doesn't support javascript.
loading
Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptor.
Haddick, Patrick C G; Tom, Irene; Luis, Elizabeth; Quiñones, Gabriel; Wranik, Bernd J; Ramani, Sree R; Stephan, Jean-Philippe; Tessier-Lavigne, Marc; Gonzalez, Lino C.
Afiliación
  • Haddick PC; Department of Neuroscience, Genentech, South San Francisco, California, United States of America.
  • Tom I; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
  • Luis E; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
  • Quiñones G; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
  • Wranik BJ; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
  • Ramani SR; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
  • Stephan JP; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
  • Tessier-Lavigne M; Department of Neuroscience, Genentech, South San Francisco, California, United States of America.
  • Gonzalez LC; Department of Protein Chemistry, Genentech, South San Francisco, California, United States of America.
PLoS One ; 9(1): e84823, 2014.
Article en En | MEDLINE | ID: mdl-24400119
ABSTRACT
The growth and guidance of many axons in the developing nervous system require Netrin-mediated activation of Deleted in Colorectal Cancer (DCC) and other still unknown signaling cues. Commissural axon guidance defects are more severe in DCC mutant mice than Netrin-1 mutant mice, suggesting additional DCC activating signals besides Netrin-1 are involved in proper axon growth. Here we report that interaction screens on extracellular protein microarrays representing over 1,000 proteins uniquely identified Cerebellin 4 (CBLN4), a member of the C1q-tumor necrosis factor (TNF) family, and Netrin-1 as extracellular DCC-binding partners. Immunofluorescence and radio-ligand binding studies demonstrate that Netrin-1 competes with CBLN4 binding at an overlapping site within the membrane-proximal fibronectin domains (FN) 4-6 of DCC and binds with ∼5-fold higher affinity. CBLN4 also binds to the DCC homolog, Neogenin-1 (NEO1), but with a lower affinity compared to DCC. CBLN4-null mice did not show a defect in commissural axons of the developing spinal cord but did display a transient increase in the number of wandering axons in the brachial plexus, consistent with a role in axon guidance. Overall, the data solidifies CBLN4 as a bona fide DCC ligand and strengthens its implication in axon guidance.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Superficie Celular / Proteínas Supresoras de Tumor Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Superficie Celular / Proteínas Supresoras de Tumor Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
...